Cargando…
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
The relationship of circulating testosterone levels with health outcomes in people with chronic obstructive pulmonary disease (COPD) is unknown. AIM: To determine whether serum testosterone levels predict hospitalised acute exacerbations of COPD (H-AECOPD), cardiovascular disease outcome, and mortal...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277522/ https://www.ncbi.nlm.nih.gov/pubmed/37316306 http://dx.doi.org/10.1136/bmjresp-2022-001601 |
_version_ | 1785060300750323712 |
---|---|
author | Pavey, Holly Polkey, Michael I Bolton, Charlotte E Cheriyan, Joseph McEniery, Carmel M Wilkinson, Ian Mohan, Divya Casaburi, Richard Miller, Bruce E Tal-Singer, Ruth Fisk, Marie |
author_facet | Pavey, Holly Polkey, Michael I Bolton, Charlotte E Cheriyan, Joseph McEniery, Carmel M Wilkinson, Ian Mohan, Divya Casaburi, Richard Miller, Bruce E Tal-Singer, Ruth Fisk, Marie |
author_sort | Pavey, Holly |
collection | PubMed |
description | The relationship of circulating testosterone levels with health outcomes in people with chronic obstructive pulmonary disease (COPD) is unknown. AIM: To determine whether serum testosterone levels predict hospitalised acute exacerbations of COPD (H-AECOPD), cardiovascular disease outcome, and mortality in people with COPD. METHODS: Separate analyses were carried out on two observational, multicentre COPD cohorts, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) and Evaluation of the Role of Inflammation in Chronic Airways Disease (ERICA), both of which had serum testosterone measured using a validated liquid chromatography assay at the same laboratory. Data from 1296 male participants in ECLIPSE and 386 male, 239 female participants in ERICA were analysed. All analyses were sex-specific. Multivariate logistic regression was used to determine associations with H-AECOPD during follow-up (3 years ECLIPSE, 4.5 years ERICA), a composite endpoint of cardiovascular hospitalisation and cardiovascular death, and all-cause mortality. RESULTS: Mean (SD) testosterone levels were consistent across cohorts; 459 (197) and 455 (200) ng/dL for males in ECLIPSE and ERICA, respectively, and in ERICA females: 28 (56) ng/dL. Testosterone was not associated with H-AECOPD (ECLIPSE: OR: 0.76, p=0.329, ERICA males: OR (95% CI): 1.06 (0.73 to 1.56), p=0.779, ERICA females: OR: 0.77 (0.52 to 1.12), p=0.178) or cardiovascular hospitalisation and death. Testosterone was associated with all-cause mortality in Global Initiative for Obstructive Lung Disease (GOLD) stage 2 male patients only, in ECLIPSE (OR: 0.25, p=0.007) and ERICA (OR: (95% CI): 0.56 (0.32 to 0.95), p=0.030). CONCLUSIONS: Testosterone levels do not relate to H-AECOPD or cardiovascular outcome in COPD, but are associated with all-cause mortality in GOLD stage 2 COPD male patients, although the clinical significance of this finding is uncertain. |
format | Online Article Text |
id | pubmed-10277522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-102775222023-06-20 Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA Pavey, Holly Polkey, Michael I Bolton, Charlotte E Cheriyan, Joseph McEniery, Carmel M Wilkinson, Ian Mohan, Divya Casaburi, Richard Miller, Bruce E Tal-Singer, Ruth Fisk, Marie BMJ Open Respir Res Chronic Obstructive Pulmonary Disease The relationship of circulating testosterone levels with health outcomes in people with chronic obstructive pulmonary disease (COPD) is unknown. AIM: To determine whether serum testosterone levels predict hospitalised acute exacerbations of COPD (H-AECOPD), cardiovascular disease outcome, and mortality in people with COPD. METHODS: Separate analyses were carried out on two observational, multicentre COPD cohorts, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) and Evaluation of the Role of Inflammation in Chronic Airways Disease (ERICA), both of which had serum testosterone measured using a validated liquid chromatography assay at the same laboratory. Data from 1296 male participants in ECLIPSE and 386 male, 239 female participants in ERICA were analysed. All analyses were sex-specific. Multivariate logistic regression was used to determine associations with H-AECOPD during follow-up (3 years ECLIPSE, 4.5 years ERICA), a composite endpoint of cardiovascular hospitalisation and cardiovascular death, and all-cause mortality. RESULTS: Mean (SD) testosterone levels were consistent across cohorts; 459 (197) and 455 (200) ng/dL for males in ECLIPSE and ERICA, respectively, and in ERICA females: 28 (56) ng/dL. Testosterone was not associated with H-AECOPD (ECLIPSE: OR: 0.76, p=0.329, ERICA males: OR (95% CI): 1.06 (0.73 to 1.56), p=0.779, ERICA females: OR: 0.77 (0.52 to 1.12), p=0.178) or cardiovascular hospitalisation and death. Testosterone was associated with all-cause mortality in Global Initiative for Obstructive Lung Disease (GOLD) stage 2 male patients only, in ECLIPSE (OR: 0.25, p=0.007) and ERICA (OR: (95% CI): 0.56 (0.32 to 0.95), p=0.030). CONCLUSIONS: Testosterone levels do not relate to H-AECOPD or cardiovascular outcome in COPD, but are associated with all-cause mortality in GOLD stage 2 COPD male patients, although the clinical significance of this finding is uncertain. BMJ Publishing Group 2023-06-14 /pmc/articles/PMC10277522/ /pubmed/37316306 http://dx.doi.org/10.1136/bmjresp-2022-001601 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Chronic Obstructive Pulmonary Disease Pavey, Holly Polkey, Michael I Bolton, Charlotte E Cheriyan, Joseph McEniery, Carmel M Wilkinson, Ian Mohan, Divya Casaburi, Richard Miller, Bruce E Tal-Singer, Ruth Fisk, Marie Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA |
title | Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA |
title_full | Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA |
title_fullStr | Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA |
title_full_unstemmed | Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA |
title_short | Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA |
title_sort | circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from eclipse and erica |
topic | Chronic Obstructive Pulmonary Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277522/ https://www.ncbi.nlm.nih.gov/pubmed/37316306 http://dx.doi.org/10.1136/bmjresp-2022-001601 |
work_keys_str_mv | AT paveyholly circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT polkeymichaeli circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT boltoncharlottee circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT cheriyanjoseph circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT mcenierycarmelm circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT wilkinsonian circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT mohandivya circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT casaburirichard circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT millerbrucee circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT talsingerruth circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica AT fiskmarie circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica |